Company News Summary
Japara Healthcare Announces Results for H1 FY2017
Original announcement: FY17 Half Year Media Release
Japara Healthcare announced its results for the half year ended 31 December 2016. The Company reported total revenue of $178.5m, up 14.5% on H1 FY16. Average underlying occupancy remained strong at 94.4%. EBITDA increased to $29.1m, up 3.6% on H1 FY16. The Company continued its good record of strong cash generation, delivering net operating cash flows of $37.4m plus net cash inflows from RADs of $29.0m. It has slightly revised its FY17 outlook, with EBITDA expected to grow at 7% - 10% on FY16. The Board has determined to pay a fully franked interim dividend of 5.5 cps on 28 April 2017. The Company's DRP will operate in respect of the interim dividend.
See more ASX300 News Announcements